The coordinated repression of E6/E7, TP63, MYC, EGFR, RAD51, and TFAP2A following JQ1 treatment highlights a therapeutically actionable SE-driven transcriptional network in HPV+ HNSCC. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.